To verify the effect of RRx-001 on Nrf2 activation, we assayed the expression of Nrf2 downstream antioxidant enzymes HO-1 and NQO1 in RRx-001 treated cells in vitro and in vivo in tumor-bearing mice. The gene discussed is NFE2L2; the disease is neoplasm.